# A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices

> **NCT06182384** · PHASE1 · COMPLETED · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 46 (actual)

## Conditions studied

- Moderate-to-Severe Plaque Psoriasis

## Interventions

- **DRUG:** SHR-1314
- **DRUG:** SHR-1314

## Key facts

- **NCT ID:** NCT06182384
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-24
- **Primary completion:** 2024-05-13
- **Final completion:** 2024-05-13
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06182384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06182384, "A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06182384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*